Skip to main content
Fig. 5 | Genome Medicine

Fig. 5

From: Implementation of next generation sequencing into pediatric hematology-oncology practice: moving beyond actionable alterations

Fig. 5

Clinical impact of WES and RNA-seq by sequencing technology. Sixty patients had full tumor/normal WES (including CNV) and RNA-seq (cWES) performed. A total of 72 clinically impactful results were found in 45/60 cases (75%). A pie chart of the overall clinical impact of cWES is presented on the left with a pie chart and table showing the number of impactful findings by sequencing technology on the right. For six patients, CNV and overexpression together yielded prognostic information in four patients with neuroblastoma and two patients with medulloblastoma

Back to article page